Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | Director | May 21, 2026 | June 11, 2026 |
| Endo International plcENDP · Entity 124463 | President, Par Pharmaceutical | April 02, 2019 | April 04, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date May 21, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,017 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 4,357 · Balance 27,017 F1: Represents a restricted stock award that will vest in full on May 21, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock award that will vest in full on May 21, 2027.
Endo International plc
Report date April 02, 2019 · Filed April 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 65,648 |
Reported balance
After 2019-04-02 transaction · row 1
1 source rowRow 1 · 2019-04-02 · Tax withholding · Disposed 11,669 · Balance 65,648 F1: Thirty-three and one-third percent (33 1/3%) of Mr. Pera's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2019. F2: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3: Represents the vesting price which is the average of the high and low share price on April 2, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Thirty-three and one-third percent (33 1/3%) of Mr. Pera's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2019.
F2: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs.
F3: Represents the vesting price which is the average of the high and low share price on April 2, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed Jun 11, 2026 01:08 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 4,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001689325-26-000003 · wk-form4_1781140099.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,017 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2027. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 20:44 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 7,292 | $94.94 | $692,302.48 |
DisclosureSEC source: 0001689325-25-000008 · wk-form4_1757018695.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,660 Read SEC document |
| August 20, 2025 Filed Aug 20, 2025 20:41 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 5,421 | $89.73 | $486,426.33 |
DisclosureSEC source: 0001689325-25-000005 · wk-form4_1755722489.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,952 F1 · price: The shares were sold in multiple trades at prices ranging from $89.27 to $90.18. The price reported above reflects the weighted average sales price. Read SEC document |
| May 22, 2025 Filed May 27, 2025 22:18 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 4,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001689325-25-000002 · wk-form4_1748384278.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,373 F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:58 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 4,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001689325-24-000005 · wk-form4_1716508672.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,037 F1 · kind: Represents a restricted stock award that will vest in full on May 21, 2025. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:20 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 7,000 | $65.20 | $456,400.00 |
DisclosureSEC source: 0001689325-24-000002 · wk-form4_1709760008.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,627 Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 00:45 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 3,000 | $60.37 | $181,110.00 |
DisclosureSEC source: 0001689325-23-000002 · wk-form4_1692146735.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,627 F1 · price: Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.12 to $60.83, inclusive. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:32 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064152 · tm2316872-3_4seq1.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,627 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:27 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 10,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004396 · form4-04292022_030409.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,762 F1 · kind: Represents a restricted stock award that will vest in full on April 27, 2023. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:31 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | PurchaseCommon Stock | 3,000 | $42.26 | $126,793.50 |
DisclosureSEC source: 0001415889-21-005801 · form4-12092021_011223.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,713 F1 · price: The shares were acquired in multiple trades at prices ranging from $42.24 to $42.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 23, 2021 Filed Mar 25, 2021 20:41 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 9,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-001658 · form4-03252021_010316.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,713 F1 · kind: Represents a restricted stock award that will vest in full on March 23, 2022. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:34 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Option (right to buy) · Derivative | 16,024 | $0.00 Strike: $31.00 | $0.00 |
DisclosureSEC source: 0001415889-20-002069 · form4-08072020_040827.xml · derivative · entry 2 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,024 Underlying: Common Stock · 16,024 shares Expires 2029-08-05 F2 · derivative.exercise_date: The option will vest and become exercisable as to 50% of the total shares on August 5, 2021 and the remaining 50% of the total shares on August 5, 2022. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:34 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 7,421 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-20-002069 · form4-08072020_040827.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,421 F1 · kind: Represents a restricted stock award that will vest as to 50% of the total shares on August 5, 2021 and the remaining 50% of the total shares on August 5, 2022. Read SEC document |
| April 02, 2019 Filed Apr 4, 2019 20:36 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 11,669 | $8.10 | $94,518.90 |
DisclosureSEC source: 0001209191-19-023659 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,648 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Pera's April 2, 2018 grant of restricted stock units (RSUs) vested on April 2, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on April 2, 2019. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:11 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 46,973 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-022383 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,118 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these restricted stock units (RSUs) generally vest, thus expire, on each of March 29, 2020, March 29, 2021 and March 29, 2022. F2 · price: These RSUs were granted to Mr. Pera in consideration of his services as President, Par Pharmaceutical, a subsidiary of Endo International plc. Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 22:35 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 186 | $10.51 | $1,954.86 |
DisclosureSEC source: 0001209191-19-013663 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,809 F1 · date: Twenty-five percent (25%) of Mr. Pera's February 23, 2016 grant of restricted stock units (RSUs) vested on February 23, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 22, 2019, the last trading day prior to vesting. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 21:49 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 2,528 | $10.38 | $26,240.64 |
DisclosureSEC source: 0001209191-19-013015 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,423 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Pera's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2019. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2019. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 20:17 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 124 | $17.05 | $2,114.20 |
DisclosureSEC source: 0001209191-18-053108 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,201 F1 · date: Twenty-five percent (25%) of Mr. Pera's October 1, 2015 grant of restricted stock units (RSUs) vested on October 1, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on October 1, 2018. Read SEC document |
| August 10, 2018 Filed Aug 14, 2018 20:09 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 5,585 | $15.82 | $88,354.70 |
DisclosureSEC source: 0001209191-18-046593 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,968 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Pera's August 10, 2017 grant of restricted stock units (RSUs) vested on August 10, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on August 10, 2018. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:51 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Restricted Stock Units (RSU) | 109,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-023556 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,796 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. One-third (1/3) of these restricted stock units (RSUs) generally vest, thus expire, on each of April 2, 2019, April 2, 2020 and April 2, 2021. F2 · price: These RSUs were granted to Mr. Pera in consideration of his services as President, Par Pharmaceutical, a subsidiary of Endo International plc. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:36 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 194 | $6.78 | $1,315.32 |
DisclosureSEC source: 0001209191-18-013933 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,581 F1 · date: Twenty-five percent (25%) of Mr. Pera's February 23, 2016 grant of restricted stock units (RSUs) vested on February 23, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 23, 2018. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:48 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 3,117 | $6.72 | $20,946.24 |
DisclosureSEC source: 0001209191-18-012700 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,203 F1 · date: Thirty-three and one-third percent (33 1/3%) of Mr. Pera's February 21, 2017 grant of restricted stock units (RSUs) vested on February 21, 2018. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on February 21, 2018. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 21:00 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 135 | $8.48 | $1,144.80 |
DisclosureSEC source: 0001209191-17-054665 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,570 F1 · date: Twenty-five percent (25%) of Mr. Pera's October 1, 2015 grant of restricted stock units (RSUs) vested on October 1, 2017. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: Represents the vesting price which is the average of the high and low share price on September 29, 2017, the last trading day prior to vesting. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 13:05 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Stock Options (NQ) · Derivative | 108,901 | $0.00 Strike: $7.55 | $0.00 |
DisclosureSEC source: 0001209191-17-048497 · doc4.xml · derivative · entry 2 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,901 Underlying: Ordinary Shares · 108,901 shares Expires 2027-08-10 F3 · security: Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc. F2 · kind: These securities were granted to Mr. Pera in consideration of his services as President, Par Pharmaceutical, a subsidiary of Endo International plc. F4 · derivative.exercise_date: These stock options are generally exercisable 33 1/3% per year on each of August 10, 2018, August 10, 2019 and August 10, 2020. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 13:05 UTC | Endo International plc ENDP · Entity 124463 | GrantStock Incentive Plan Restricted Stock Units (RSU) | 47,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048497 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,952 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. These restricted stock units (RSUs) generally vest 33 1/3% per year on each of August 10, 2018, August 10, 2019 and August 10, 2020. Upon vesting, we consider the underlying RSUs to be expired. F2 · kind: These securities were granted to Mr. Pera in consideration of his services as President, Par Pharmaceutical, a subsidiary of Endo International plc. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 19:53 UTC | Endo International plc ENDP · Entity 124463 | Tax withholdingOrdinary Shares | 247 | $13.22 | $3,265.34 |
DisclosureSEC source: 0001209191-17-014663 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,348 F1 · date: Twenty-five percent (25%) of Mr. Pera's February 23, 2016 grant of restricted stock units (RSUs) vested on February 23, 2017. F2 · shares: These shares represent stock withheld by Endo International plc to satisfy Mr. Pera's tax withholding obligations on shares acquired upon vesting of RSUs. F3 · price: $13.22 represents the vesting price, which is the average of the high and low share price on February 23, 2017. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 22:05 UTC | Endo International plc ENDP · Entity 124463 | Grant2015 Stock Incentive Plan Stock Options (NQ) · Derivative | 52,154 | Not disclosed Strike: $13.19 | Not disclosed |
DisclosureSEC source: 0001209191-17-013870 · doc4.xml · derivative · entry 2 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,154 Underlying: Ordinary Shares · 52,154 shares Expires 2027-02-21 F3 · security: Represents the right to buy ordinary shares, par value $0.0001 per share, of Endo International plc. F2 · price: These securities were granted to Mr. Pera in consideration of his services as President, Par Pharmaceutical, a subsidiary of Endo International plc. F4 · derivative.exercise_date: These stock options are generally exercisable 25% per year on each of February 21, 2018, February 21, 2019, February 21, 2020 and February 21, 2021. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 22:05 UTC | Endo International plc ENDP · Entity 124463 | GrantStock Incentive Plan Restricted Stock Units (RSU) | 23,249 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-013870 · doc4.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · President, Par Pharmaceutical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,609 F1 · security: Upon each vesting date, each vested restricted stock unit automatically converts into one (1) ordinary share of Endo International plc. These restricted stock units (RSUs) generally vest 33 1/3% per year on each of February 21, 2018, February 21, 2019 and February 21, 2020. Upon vesting, we consider the underlying RSUs to be expired. F2 · price: These securities were granted to Mr. Pera in consideration of his services as President, Par Pharmaceutical, a subsidiary of Endo International plc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.